EarningsQ4 2025 Earnings Report

ANI Pharmaceuticals (BSFA) Q4 2025 Earnings Report

0 Followers

DE:BSFA Q4 2025 EPS Results

Actual EPS€2.07

Consensus EPS€1.77

Beat/MissBeat by +€0.30

One Year Ago EPS€1.45

Actual Revenue€219.82M

Expected Revenue€205.61M

Beat/MissBeat by +€14.21M

YoY Revenue Growth+29.64%

QuarterQ4 2025

Date03/03/2026

TimeBefore Open

Conference CallTuesday, March 3, 2026

DE:BSFA Upcoming Earnings

ANI Pharmaceuticals's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

DE:BSFA Q4 2025 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 11, 2026	2026 (Q3)	1.94 / -	1.815	―
Aug 07, 2026	2026 (Q2)	1.82 / 1.97	1.602	22.78% (+0.36)
May 08, 2026	2026 (Q1)	1.16 / 1.82	1.513	20.59% (+0.31)
Mar 03, 2026	2025 (Q4)	1.77 / 2.07	1.45	42.94% (+0.62)
Nov 10, 2025	2025 (Q3)	1.57 / 1.82	1.192	52.24% (+0.62)
Aug 08, 2025	2025 (Q2)	1.25 / 1.60	0.908	76.47% (+0.69)
May 09, 2025	2025 (Q1)	1.23 / 1.51	1.077	40.50% (+0.44)
Feb 28, 2025	2024 (Q4)	1.28 / 1.45	0.89	63.00% (+0.56)
Nov 08, 2024	2024 (Q3)	0.97 / 1.19	1.13	5.51% (+0.06)
Aug 06, 2024	2024 (Q2)	0.85 / 0.91	1.139	-20.31% (-0.23)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed